These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 16538414)

  • 21. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.
    Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC
    Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of extensive lymph node dissection on the survival of early gastric cancer.
    Ohgaki M; Toshio T; Akeo H; Yamasaki J; Togawa T
    Hepatogastroenterology; 1999; 46(27):2096-9. PubMed ID: 10430404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501).
    Tsujinaka T; Sasako M; Yamamoto S; Sano T; Kurokawa Y; Nashimoto A; Kurita A; Katai H; Shimizu T; Furukawa H; Inoue S; Hiratsuka M; Kinoshita T; Arai K; Yamamura Y;
    Ann Surg Oncol; 2007 Feb; 14(2):355-61. PubMed ID: 17146738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can superextended lymph node dissection be justified for gastric cancer with pathologically positive para-aortic lymph nodes?
    Tokunaga M; Ohyama S; Hiki N; Fukunaga T; Aikou S; Yamaguchi T
    Ann Surg Oncol; 2010 Aug; 17(8):2031-6. PubMed ID: 20182811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lymph node metastasis and the extent of lymph node dissection for gastric cancer: report of 326 cases].
    Wan Y; Pan Y; Liu Y; Wang Z; Ye J; Huang S
    Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):752-5. PubMed ID: 11832155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymph node metastasis in gastric cancer: result of D2 dissection.
    Methasate A; Trakarnsanga A; Akaraviputh T; Chinsawangwathanakol V; Lohsiriwat D
    J Med Assoc Thai; 2010 Mar; 93(3):310-7. PubMed ID: 20420105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perigastric lymph node status as a prognostic indicator in patients with gastric cancer.
    Adachi Y; Suematsu T; Shiraishi N; Tanimura H; Morimoto A; Kitano S
    Br J Surg; 1998 Sep; 85(9):1281-4. PubMed ID: 9752878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.
    Sasako M; Sano T; Yamamoto S; Kurokawa Y; Nashimoto A; Kurita A; Hiratsuka M; Tsujinaka T; Kinoshita T; Arai K; Yamamura Y; Okajima K;
    N Engl J Med; 2008 Jul; 359(5):453-62. PubMed ID: 18669424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
    Roukos DH; Lorenz M; Encke A
    Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do patients with pN0 gastric cancer benefit from prophylactic extended lymphadenectomy?
    Sun D; Gong R; Wu H
    Surg Oncol; 2012 Mar; 21(1):e7-11. PubMed ID: 22071221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results and controversial issues regarding a para-aortic lymph node dissection for advanced gastric cancer.
    Takashima S; Kosaka T
    Surg Today; 2005; 35(6):425-31. PubMed ID: 15912287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative study of D1 and D2 ganglionic dissection in advanced gastric cancer at Rebagliati Hospital].
    Cornejo C; Portanova M
    Rev Gastroenterol Peru; 2006; 26(4):351-6. PubMed ID: 17211484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective randomized study comparing open versus laparoscopy-assisted D2 radical gastrectomy in advanced gastric cancer.
    Cai J; Wei D; Gao CF; Zhang CS; Zhang H; Zhao T
    Dig Surg; 2011; 28(5-6):331-7. PubMed ID: 21934308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [D2 lymph node dissection in gastric cancer surgery: long term results--analysis of an experience with 227 patients].
    Vasilescu C; Herlea V; Tidor S; Ivanov B; Stănciulea O; Mănuc M; Gheorghe C; Ionescu M; Diculescu M; Popescu I
    Chirurgia (Bucur); 2006; 101(4):375-84. PubMed ID: 17059148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing outcome in gastric cancer involving muscularis and subserosal layer.
    Fotia G; Marrelli D; De Stefano A; Pinto E; Roviello F
    Eur J Surg Oncol; 2004 Nov; 30(9):930-4. PubMed ID: 15498636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of a paraaortic node dissection for selected advanced gastric cancer patients.
    Shimoyama S; Mafune K; Kaminishi M
    Hepatogastroenterology; 2005; 52(65):1631-5. PubMed ID: 16201131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution.
    Kasakura Y; Mochizuki F; Wakabayashi K; Kochi M; Fujii M; Takayama T
    J Surg Res; 2002 Apr; 103(2):252-9. PubMed ID: 11922742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended lymph-node dissection for gastric cancer.
    Bonenkamp JJ; Hermans J; Sasako M; van de Velde CJ; Welvaart K; Songun I; Meyer S; Plukker JT; Van Elk P; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H;
    N Engl J Med; 1999 Mar; 340(12):908-14. PubMed ID: 10089184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical treatment of advanced gastric cancer with metastasis in para-aortic lymph node.
    Yonemura Y; Katayama K; Kamata T; Fushida S; Segawa M; Ooyama S; Miwa K; Miyazaki I
    Int Surg; 1991; 76(4):222-5. PubMed ID: 1778720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer.
    Onodera H; Tokunaga A; Yoshiyuki T; Kiyama T; Kato S; Matsukura N; Masuda G; Tajiri T
    Hepatogastroenterology; 2004; 51(55):82-5. PubMed ID: 15011835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.